Tirzepatide - 10mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide designed for advanced metabolic research. This 10mg lyophilized formulation supports studies into blood sugar regulation, appetite signaling, and body composition. Known for its dual-pathway mechanism, Tirzepatide is a leading compound for researchers investigating next-generation metabolic and weight management science. Each vial delivers a precise 10mg concentration for consistent, reliable results.
Certificate of Analysis (Janoshik Analytical): Batch TR26061602. Purity 99.315%. Content 12.88mg per vial. Analysis conducted 04 AUG 2026. Task #209843, verify at janoshik.com/verify with key 5J56JAMQP3R7.
Not for Human Consumption
This product is intended exclusively for educational and research purposes. It is not intended for human or animal use.
All information provided on this website is for educational and research purposes only and is not a substitute for professional medical advice.
These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.